Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

NCT04274829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-02-18

No results posted yet for this study

Summary

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Conditions

Interventions

PROCEDURE

Thyroidecomt and lymphectomy

Patients underwent total thyroidectomy or lobectomy associated to lymph node sampling or neck lymphectomy

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2018-01-31
Completion
2020-02-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274829 on ClinicalTrials.gov